Should central obesity be an optional or essential component of the metabolic syndrome? Ischemic heart disease risk in the Singapore Cardiovascular Cohort Study
- PMID: 17259505
- DOI: 10.2337/dc06-1866
Should central obesity be an optional or essential component of the metabolic syndrome? Ischemic heart disease risk in the Singapore Cardiovascular Cohort Study
Abstract
Objective: The International Diabetes Federation (IDF) proposes that central obesity is an "essential" component of the metabolic syndrome, while the American Heart Association/National Heart, Lung, and Blood Institute (AHA/NHLBI) proposes that central obesity is an "optional" component. This study examines the effect of the metabolic syndrome with and without central obesity in an Asian population with ischemic heart disease (IHD).
Research design and methods: From the population-based cohort study (baseline 1992-1995), 4,334 healthy individuals were grouped by the presence or absence of the metabolic syndrome and central obesity and followed up for an average of 9.6 years by linkage with three national registries. Cox's proportional hazards model was used to obtain adjusted hazard ratios (HRs) for risk of a first IHD event.
Results: The prevalence of metabolic syndrome was 17.7% by IDF criteria and 26.2% by AHA/NHLBI criteria using Asian waist circumference cutoff points for central obesity. Asian Indians had higher rates than Chinese and Malays. There were 135 first IHD events. Compared with individuals without metabolic syndrome, those with central obesity/metabolic syndrome and no central obesity/metabolic syndrome were at significantly increased risk of IHD, with adjusted HRs of 2.8 (95% CI 1.8-4.2) and 2.5 (1.5-4.0), respectively.
Conclusions: Having metabolic syndrome either with or without central obesity confers IHD risk. However, having central obesity as an "optional" rather than "essential" criterion identifies more individuals at risk of IHD in this Asian cohort.
Similar articles
-
The impact of central obesity as a prerequisite for the diagnosis of metabolic syndrome.Obesity (Silver Spring). 2007 Jan;15(1):262-9. doi: 10.1038/oby.2007.559. Obesity (Silver Spring). 2007. PMID: 17228055
-
The metabolic syndrome and mortality: the Singapore Cardiovascular Cohort Study.Clin Endocrinol (Oxf). 2008 Aug;69(2):225-30. doi: 10.1111/j.1365-2265.2008.03174.x. Epub 2008 Jan 15. Clin Endocrinol (Oxf). 2008. PMID: 18208579
-
The impact of the metabolic syndrome and its components on the incidence of ischemic heart disease and stroke: the Japan public health center-based study.Hypertens Res. 2009 Apr;32(4):289-98. doi: 10.1038/hr.2009.14. Epub 2009 Feb 27. Hypertens Res. 2009. PMID: 19262490
-
Epidemiology of metabolic syndrome in Asia.Asia Pac J Clin Nutr. 2008;17 Suppl 1:37-42. Asia Pac J Clin Nutr. 2008. PMID: 18296297 Review.
-
What is the contribution of obesity to the metabolic syndrome?Endocrinol Metab Clin North Am. 2004 Jun;33(2):267-82, table of contents. doi: 10.1016/j.ecl.2004.03.001. Endocrinol Metab Clin North Am. 2004. PMID: 15158519 Review.
Cited by
-
Prevalence of Metabolic Syndrome in Patients with Lichen Planus: A Cross-sectional Study from a Tertiary Care Center.Indian Dermatol Online J. 2018 Sep-Oct;9(5):304-308. doi: 10.4103/idoj.IDOJ_27_18. Indian Dermatol Online J. 2018. PMID: 30258796 Free PMC article.
-
Metabolic syndrome & Framingham Risk Score: observations from a coronary angiographic study in Indian patients.Indian J Med Res. 2013 Feb;137(2):295-301. Indian J Med Res. 2013. PMID: 23563372 Free PMC article.
-
Combined effect of body mass index and metabolic status on the risk of prevalent and incident chronic kidney disease: a systematic review and meta-analysis.Oncotarget. 2017 May 30;8(22):35619-35629. doi: 10.18632/oncotarget.10915. Oncotarget. 2017. PMID: 27579531 Free PMC article.
-
The effectiveness of IDF and ATP-III in identifying metabolic syndrome and the usefulness of these tools for health-promotion in older Taiwanese.J Nutr Health Aging. 2013 Apr;17(4):413-6. doi: 10.1007/s12603-012-0440-2. J Nutr Health Aging. 2013. PMID: 23538668
-
Prevalence and component analysis of metabolic syndrome: an Indian atherosclerosis research study perspective.Vasc Health Risk Manag. 2008;4(1):189-97. doi: 10.2147/vhrm.2008.04.01.189. Vasc Health Risk Manag. 2008. PMID: 18629355 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical